Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy-Reference-Cited by-同舟云学术

Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy

Published:2015-06-23 Issue:8 Volume:21 Page:1066-1075
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Turan Ilker¹,Yapali Suna¹,Bademkiran Fikret²,Kose Timur³,Duman Soner⁴,Sozbilen Murat⁵,Gunsar Fulya¹,Ersoz Galip¹,Akarca Ulus Salih¹,Ozutemiz Omer¹,Karasu Zeki¹

Affiliation:

1. Section of Gastroenterology, School of Medicine; Ege University; Izmir Turkey

2. Department of Neurology, School of Medicine; Ege University; Izmir Turkey

3. Department of Biostatistics, School of Medicine; Ege University; Izmir Turkey

4. Section of Nephrology, School of Medicine; Ege University; Izmir Turkey

5. Department of Organ Transplantation and Research Center, School of Medicine; Ege University; Izmir Turkey

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.24131/fullpdf

Reference44 articles.

1. Living donor liver transplantation for hepatitis B cirrhosis;Karasu;J Gastroenterol Hepatol,2007

2. Liver Transplantation for Chronic Hepatitis B and C

3. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation;Lucey;Liver Transpl,2013

4. Current management of hepatitis B virus infection before and after liver transplantation;Papatheodoridis;Liver Int,2009

5. Management of hepatitis B in liver transplantation patients;Samuel;Semin Liver Dis,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxic Myopathies;Current Treatment Options in Neurology;2022-05-04

2. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantation;European Journal of Inflammation;2022-01

3. Evaluation of Clinical Neuropathy After Living Donor Liver Transplant;Experimental and Clinical Transplantation;2021-07

4. Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination;Clinical and Experimental Nephrology;2020-03-26

5. Toxic Myopathies;CONTINUUM: Lifelong Learning in Neurology;2019-12